Research Article

Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study

Volume: 18 Number: 3 October 27, 2026

Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study

Abstract

Aim: This study aimed to evaluate five-year clinical outcomes and investigate baseline factors associated with major adverse cardiovascular events (MACE) in patients presenting with transient ST-segment elevation myocardial infarction (STEMI).

Material and Methods: This retrospective, single-center, observational study included 52 patients who presented between January 2019 and December 2020 with ST-segment elevation on the initial electrocardiogram followed by complete resolution before coronary angiography. The primary outcome was five-year MACE, defined as a composite of cardiovascular death, acute coronary syndrome, revascularization, and ischemic cerebrovascular events. Follow-up data were obtained from hospital records and the national electronic health record system. Patients with and without MACE were compared, and associated factors were examined using univariable logistic regression.

Results: The median age was 54.5 years, and 80.8% of patients were male. During five-year follow-up, MACE occurred in 11 patients (21.2%). All-cause mortality was 7.7%, cardiovascular mortality was 1.9%, and acute coronary syndrome and revascularization each occurred in 15.4%. Patients with MACE were older (63.0 vs. 51.0 years; p=0.003) and more frequently had hypertension (72.7% vs. 29.3%; p=0.014) and hyperlipidemia (45.5% vs. 12.2%; p=0.025). In univariable analysis, age (OR: 1.09; 95% CI: 1.02-1.17; p=0.016), hypertension (OR: 6.44; 95% CI: 1.46-28.53; p=0.014), and hyperlipidemia (OR: 6.00; 95% CI: 1.32-27.19; p=0.020) were significantly associated with five-year MACE.

Conclusion: Long-term cardiovascular risk was not negligible after transient STEMI despite resolution of ST-segment elevation. Age, hypertension, and hyperlipidemia were associated with five-year MACE in univariable analyses and may help identify patients at higher long-term cardiovascular risk.

Keywords

References

  1. Ferrari R, Balla C, Malagù M, Guardigli G, Morciano G, Bertini M, et al. Reperfusion damage: a story of success, failure, and hope. Circ J. 2017;81(2):131-41. doi:10.1253/circj.CJ-16-1124.
  2. Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part II. Mayo Clin Proc. 2009;84(11):1021-36. doi:10.1016/S0025-6196(11)60674-5.
  3. Janssens GN, van der Hoeven NW, Lemkes JS, Everaars H, van de Ven PM, Marques KMJ, et al. 1-year outcomes of delayed versus immediate intervention in patients with transient ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2019;12(22):2272-82. doi:10.1016/j.jcin.2019.07.018.
  4. Leader JH, Kanji R, Gorog DA. Spontaneous reperfusion in STEMI: its mechanisms and possible modulation. Kardiol Pol. 2024;82(4):363-74. doi:10.33963/v.phj.99737.
  5. Blondheim DS, Kleiner-Shochat M, Asif A, Kazatsker M, Frimerman A, Abu-Fanne R, et al. Characteristics, management, and outcome of transient ST-elevation versus persistent ST-elevation and non-ST-elevation myocardial infarction. Am J Cardiol. 2018;121(12):1449-55. doi:10.1016/j.amjcard.2018.02.029.
  6. Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med. 1987;317(17):1055-9. doi:10.1056/NEJM198710223171704.
  7. Meisel SR, Dagan Y, Blondheim DS, Dacca S, Shochat M, Kazatsker M, et al. Transient ST-elevation myocardial infarction: clinical course with intense medical therapy and early invasive approach, and comparison with persistent ST-elevation myocardial infarction. Am Heart J. 2008;155(5):848-54. doi:10.1016/j.ahj.2007.12.010.
  8. Lemkes JS, Janssens GN, van der Hoeven NW, van de Ven PM, Marques KMJ, Nap A, et al. Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial. Eur Heart J. 2019;40(3):283-91. doi:10.1093/eurheartj/ehy651.

Details

Primary Language

English

Subjects

Health Services and Systems (Other)

Journal Section

Research Article

Publication Date

October 27, 2026

Submission Date

August 2, 2026

Acceptance Date

October 12, 2026

Published in Issue

Year 2026 Volume: 18 Number: 3

APA
Yılmaz, D., & Çakmak, A. C. (2026). Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study. Konuralp Medical Journal, 18(3), 272-280. https://doi.org/10.18521/ktd.2009362
AMA
1.Yılmaz D, Çakmak AC. Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study. Konuralp Medical Journal. 2026;18(3):272-280. doi:10.18521/ktd.2009362
Chicago
Yılmaz, Direnç, and Ahmet Can Çakmak. 2026. “Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study”. Konuralp Medical Journal 18 (3): 272-80. https://doi.org/10.18521/ktd.2009362.
EndNote
Yılmaz D, Çakmak AC (October 1, 2026) Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study. Konuralp Medical Journal 18 3 272–280.
IEEE
[1]D. Yılmaz and A. C. Çakmak, “Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study”, Konuralp Medical Journal, vol. 18, no. 3, pp. 272–280, Oct. 2026, doi: 10.18521/ktd.2009362.
ISNAD
Yılmaz, Direnç - Çakmak, Ahmet Can. “Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study”. Konuralp Medical Journal 18/3 (October 1, 2026): 272-280. https://doi.org/10.18521/ktd.2009362.
JAMA
1.Yılmaz D, Çakmak AC. Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study. Konuralp Medical Journal. 2026;18:272–280.
MLA
Yılmaz, Direnç, and Ahmet Can Çakmak. “Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study”. Konuralp Medical Journal, vol. 18, no. 3, Oct. 2026, pp. 272-80, doi:10.18521/ktd.2009362.
Vancouver
1.Direnç Yılmaz, Ahmet Can Çakmak. Five-Year Clinical Outcomes and Factors Associated With Major Adverse Cardiovascular Events in Transient ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study. Konuralp Medical Journal. 2026 Oct. 1;18(3):272-80. doi:10.18521/ktd.2009362

https://mjl.clarivate.com://search-results?issn=1309-3878&hide_exact_match_fl=true&utm_source=mjl&utm_medium=share-by-link&utm_campaign=search-results-share-this-journal

 

EBSCO - Research Databases, EBooks, Discovery Service

5bd95eb5f3a21.jpg